Pfizer
Tom Van den Eede has a diverse work experience spanning over several companies and roles. Tom currently holds the position of Team Lead Infrastructure Operational Technology at Pfizer, starting in 2021. Prior to that, they worked as a Business Technology Project Manager for Pfizer Puurs at DXC Technology from 2019 to 2021. From 2016 to 2018, they held the roles of Service Delivery Site Leader P&G Account BeNl and Client Capability Lead for Duracell Site Services EMEA at DXC Technology. Tom also worked at Hewlett-Packard, where they served as a Service Delivery Manager for P&G account Belgium/Nehterlands from 2014 to 2016, a Resource Manager IT EMEA - Project Services from 2011 to 2014, and a Project Manager from 2009 to 2011. Tom Van den Eede holds a teaching position at Karel de Grote-Hogeschool and the University of Antwerp earlier in their career.
Tom Van den Eede obtained a Master's degree in Mathematics and Computer Science from the University of Antwerp, which they attended from 1989 to 1997. Prior to that, they completed their secondary education at SJB Malle from 1978 to 1989.
This person is not in any teams
This person is not in any offices
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.